查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1869638

核酸增幅检查市场规模、份额和趋势分析报告：按类型、应用、最终用途、地区和细分市场预测（2025-2033 年）

Nucleic Acid Amplification Testing Market Size, Share & Trends Analysis By Type, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

核酸增幅检查市场摘要

2024年全球核酸增幅检查市场规模估计为99.5682亿美元，预计到2033年将达到231.4669亿美元。

预计从 2025 年到 2033 年，该行业将以 9.30% 的复合年增长率成长。这一增长主要受几个关键因素的驱动，例如感染疾病的日益流行、向照护现场(POC) 的转变、分子诊断技术的进步、分散式检查以及对个性化医疗日益增长的需求。

新冠肺炎、肝炎和爱滋病等感染疾病在全球日益加重，凸显了快速、准确的诊断工具（例如高灵敏度和特异性的核酸增幅检查）的重要性。此外，即时PCR、等温扩增方法和自动化系统等持续的技术创新，正在提高临床和非临床环境中检测的效率、速度和可及性。

例如，2023年6月，美国食品药物管理局（FDA）核准了Cue COVID-19分子检测试剂盒上市，该试剂盒是一种用于检测有症状成年人鼻拭子样本中SARS-CoV-2病毒遗传物质的分子核酸扩增检测（NAAT）试剂盒。值得注意的是，这是第一个经由传统上市前审查途径核准的商用家用分子检测套组（适用于整体呼吸道疾病）。这项突破性进展反映了以患者为中心的诊断模式的转变，以及家用检测在公共卫生监测中日益增长的重要性。

此外，核酸增幅检查（NAAT）的应用范围正从感染疾病诊断扩展到肿瘤学、基因筛检和药物遗传学等领域，凸显了其在精准医疗时代的重要性。各国政府和医疗机构也加大对疾病早期检测计画和检查室基础设施的投入，以促进市场成长。然而，检测设备高成本、监管复杂以及资源匮乏地区难以取得检测服务等挑战，仍是NAAT广泛应用的主要障碍。

最后，随着技术创新、医疗保健分散化以及个人化医疗的发展，全球核酸扩增产业预计将稳​​定扩张，进而提升全球诊断能力。在持续的研发投入和完善的法规结构支持下，核酸扩增技术可望在未来十年继续成为现代分子诊断的基础。

此外，大规模筛检计画的实施和推广，特别是政府和医疗机构主导的项目，显着提高了疾病的检出率和管理水平。这些措施促进了定期体检和基因检测，从而推动了核酸扩增技术的广泛应用。癌症、囊肿纤维化和遗传性血液疾病等慢性病和遗传性疾病的日益普遍，促使人们迫切需要精准的分子诊断解决方案，以实现早期发现和标靶治疗。

此外，自动化与人工智慧 (AI)、机器学习、机器人技术和微流体等先进技术的融合显着提高了检测的灵敏度、通量和结果出具速度。自动化核酸扩增技术 (NAAT) 系统在中心检查室和照护现场(POC) 环境中正变得越来越实用，因为它们减少了人工干预，降低了人为误差，并提高了工作流程效用。携带式和多重检测平台的进步正在提高资源匮乏地区分子检测的可及性。

此外，来自公共卫生机构、国际组织和私人投资者的监管核准和资金筹措倡议正在促进创新和产品商业化。加速监管审批流程、公私合营以及政府对疫情防范的投入，都有助于尖端核酸扩增检测（NAAT）产品在全球的普及应用。这些因素不仅加强了诊断基础设施，也为市场的长期成长奠定了基础。

目录

第一章核酸增幅检查市场：调查方法与范围

第二章核酸增幅检查市场：执行摘要

  • 市场概述
  • 类型
  • 应用程式简介
  • 技术概览
  • 最终用途简介
  • 竞争格局概览

第三章核酸增幅检查市场变数、趋势与范围

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
  • 市场驱动因素分析
    • 全球季节性流感和通用流感的发生率和严重程度都在增加。
    • 感染疾病率增加
    • 分子诊断技术的进展
    • 照护现场(POC) 与分散式检查的转变
    • 精准医疗/个人化医疗和基因检测的需求日益增长
  • 市场限制因素分析
    • 熟练人员短缺和基础设施有限
  • 波特五力分析
  • PESTLE分析
  • 管道分析

第四章核酸增幅检查市场：按类型分類的估计和趋势分析

  • 核酸增幅检查市场：按类型分類的差异分析
  • 核酸增幅检查市场：依检测方式分類的展望
  • 聚合酵素链锁反应（PCR）检测
  • 恒温核酸增幅技术（INAAT）检测
  • 连接酶炼式反应 (LCR) 检测

第五章核酸增幅检查市场：依应用分類的估计与趋势分析

  • 核酸增幅检查市场：依应用分類的差异分析
  • 核酸增幅检查市场：按应用领域分類的展望
  • 传染病检查
    • 新冠病毒检测
    • 蚊媒疾病检测
    • 流感检测
    • 性行为感染传染病检测
    • 肝炎检测
    • 结核病检测
    • 其他的
  • 肿瘤检测
  • 基因和粒线体疾病检测
  • 其他的

第六章核酸增幅检查市场：终端使用者需求预测与趋势分析

  • 核酸增幅检查市场：终端用途差异分析
  • 核酸增幅检查市场：依最终用途分類的展望
  • 医院
  • 中央实验室和参考实验室
  • 其他的

第七章核酸增幅检查市场：按地区分類的业务分析

  • 区域市场概况
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

第八章 竞争情势

  • 公司分类
  • 策略规划
    • 新产品上市
    • 伙伴关係
    • 获得
    • 合作
    • 资金筹措
  • 主要企业市占率分析，2024 年
  • 公司热力图分析
  • 公司简介
    • F. Hoffmann-La Roche Ltd
    • Molbio Diagnostics Limited
    • Becton, Dickinson and Company
    • Danaher Corporation
    • Abbott Laboratories
    • Illumina, Inc.
    • Siemens Healthineers
    • bioMerieux SA
    • Bio-Rad Laboratories, Inc.
    • Seegene Inc.
Product Code: GVR-1-68038-388-1

Nucleic Acid Amplification Testing Market Summary

The global nucleic acid amplification testing market size was estimated at USD 9,956.82 million in 2024 and is projected to reach USD 23,146.69 million by 2033, growing at a CAGR of 9.30% from 2025 to 2033. This growth is primarily driven by several key factors, including the rising prevalence of infectious diseases, a shift toward point-of-care (POC), advancements in molecular diagnostic technologies, decentralized testing, and the growing demand for personalized medicine.

The rising global burden of infectious diseases such as COVID-19, hepatitis, and HIV continues to underscore the importance of rapid and accurate diagnostic tools like NAAT, which offer high sensitivity and specificity. Moreover, continuous technological innovations, such as real-time PCR, isothermal amplification methods, and automated systems, enhance testing efficiency, speed, and accessibility across clinical and non-clinical settings.

For instance, in June 2023, the U.S. Food and Drug Administration granted marketing authorization for the Cue COVID-19 Molecular Test, a molecular NAAT designed to detect SARS-CoV-2 genetic material from nasal swabs in symptomatic adults. Notably, this was the first at-home, over-the-counter molecular test for any respiratory illness to be approved using a traditional premarket review pathway. This milestone reflects the ongoing shift toward patient-centered diagnostics and the growing importance of home-based testing in public health surveillance.

Furthermore, the use of NAAT is expanding beyond infectious disease diagnostics to oncology, genetic screening, and pharmacogenomics, highlighting its importance in the era of precision medicine. Governments and healthcare organizations are also investing in early disease detection programs and laboratory infrastructure to help drive market growth. However, challenges such as high testing equipment costs, regulatory complexities, and limited access in low-resource settings continue to impede widespread adoption.

Finally, the global nucleic acid amplification industry is expected to expand steadily as technological innovation, healthcare decentralization, and the pursuit of personalized medicine work together to improve diagnostic capabilities around the world. With continued R&D investment and supportive regulatory frameworks, NAAT is expected to remain a cornerstone of modern molecular diagnostics for the next decade.

Furthermore, increasing awareness and implementing large-scale screening programs, particularly those initiated by governments and healthcare organizations, significantly improves disease detection and management. These initiatives promote regular health check-ups and genetic testing, which increases the use of nucleic acid amplification technologies. The rising prevalence of chronic and genetic disorders, such as cancer, cystic fibrosis, and hereditary blood diseases, has increased the need for precise molecular diagnostic solutions that allow for early detection and targeted treatment planning.

Moreover, the integration of advanced technologies and automation such as artificial intelligence (AI), machine learning, robotics, and microfluidics has significantly improved test sensitivity, throughput, and turnaround time. Automated NAAT systems reduce manual intervention, reduce human error, and improve workflow efficiency, making them more useful in both centralized laboratories and point-of-care (POC) settings. The advancement of portable and multiplexed platforms is increasing the accessibility of molecular testing to resource-constrained regions.

Furthermore, regulatory approvals and funding initiatives by public health authorities, international organizations, and private investors encourage innovation and product commercialization. Accelerated regulatory pathways, public-private partnerships, and government investments in pandemic preparedness have all helped to increase the global availability of cutting-edge NAAT products. These combined factors not only enhance diagnostic infrastructure but also lay the groundwork for long-term market growth.

Global Nucleic Acid Amplification Testing Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global nucleic acid amplification testing market based on type, application, technology, end use, and region:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Polymerase Chain Reaction (PCR) Tests
  • Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
  • Ligase Chain Reaction (LCR) Tests
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Infectious Disease Testing
    • COVID-19 Testing
    • Mosquito-Borne Disease Testing
    • Influenza Testing
    • Sexually Transmitted Infections Testing
    • Hepatitis Testing
    • Tuberculosis Testing
    • Others
  • Oncology Testing
  • Genetic & Mitochondrial Disease Testing
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Central and Reference Laboratories
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Nucleic Acid Amplification Testing Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Type
      • 1.1.1.2. Application Segment
      • 1.1.1.3. Technology Segment
      • 1.1.1.4. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Influenza Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Nucleic Acid Amplification Testing Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Type
  • 2.3. Application Snapshot
  • 2.4. Technology Snapshot
  • 2.5. End Use Snapshot
  • 2.6. Competitive Landscape Snapshot

Chapter 3. Nucleic Acid Amplification Testing Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Increasing global prevalence and severity of seasonal and zoonotic influenza outbreaks
    • 3.4.2. Rising prevalence of infectious diseases
    • 3.4.3. Advancements in molecular diagnostic technologies
    • 3.4.4. Shift toward point-of-care (POC) and decentralized testing
    • 3.4.5. Growing demand for precision/personalized medicine and genetic diagnostics
  • 3.5. Market Restraint Analysis
    • 3.5.1. Shortage of skilled personnel and infrastructure limitations
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis
  • 3.8. Pipeline Analysis

Chapter 4. Nucleic Acid Amplification Testing Market: Type Estimates & Trend Analysis

  • 4.1. Nucleic Acid Amplification Testing Market: Type Movement Analysis
  • 4.2. Nucleic Acid Amplification Testing Market by Test Outlook (USD Million)
  • 4.3. Polymerase Chain Reaction (PCR) Tests
    • 4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
    • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Ligase Chain Reaction (LCR) Tests
    • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Nucleic Acid Amplification Testing Market: Application Estimates & Trend Analysis

  • 5.1. Nucleic Acid Amplification Testing Market: Application Movement Analysis
  • 5.2. Nucleic Acid Amplification Testing Market by Application Outlook (USD Million)
  • 5.3. Infectious Disease Testing
    • 5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.2. COVID-19 Testing
      • 5.3.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.3. Mosquito-Borne Disease Testing
      • 5.3.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.4. Influenza Testing
      • 5.3.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.5. Sexually Transmitted Infections Testing
      • 5.3.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.6. Hepatitis Testing
      • 5.3.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.7. Tuberculosis Testing
      • 5.3.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.8. Others
      • 5.3.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Oncology Testing
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Genetic & Mitochondrial Disease Testing
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Others
    • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Nucleic Acid Amplification Testing Market: End Use Estimates & Trend Analysis

  • 6.1. Nucleic Acid Amplification Testing Market: End Use Movement Analysis
  • 6.2. Nucleic Acid Amplification Testing Market by End use Outlook (USD Million)
  • 6.3. Hospitals
    • 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Central And Reference Laboratories
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Others
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Nucleic Acid Amplification Testing Market: Regional Business Analysis

  • 7.1. Regional Market Snapshot
  • 7.2. North America
    • 7.2.1. North America Nucleic Acid Amplification Testing Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.2.2.2. Key Country Dynamics
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. Reimbursement Scenario
      • 7.2.2.5. Competitive Scenario
    • 7.2.3. Canada
      • 7.2.3.1. Canada Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.2.3.2. Key Country Dynamics
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Reimbursement Scenario
      • 7.2.3.5. Competitive Scenario
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.2.4.2. Key Country Dynamics
      • 7.2.4.3. Regulatory Framework
      • 7.2.4.4. Reimbursement Scenario
      • 7.2.4.5. Competitive Scenario
  • 7.3. Europe
    • 7.3.1. Europe Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.3.2.2. Key Country Dynamics
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. Reimbursement Scenario
      • 7.3.2.5. Competitive Scenario
    • 7.3.3. Germany
      • 7.3.3.1. Germany Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.3.3.2. Key Country Dynamics
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Reimbursement Scenario
      • 7.3.3.5. Competitive Scenario
    • 7.3.4. Spain
      • 7.3.4.1. Spain Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.3.4.2. Key Country Dynamics
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Reimbursement Scenario
      • 7.3.4.5. Competitive Scenario
    • 7.3.5. France
      • 7.3.5.1. France Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.3.5.2. Key Country Dynamics
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Reimbursement Scenario
      • 7.3.5.5. Competitive Scenario
    • 7.3.6. Italy
      • 7.3.6.1. Italy Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.3.6.2. Key Country Dynamics
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Reimbursement Scenario
      • 7.3.6.5. Competitive Scenario
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.3.7.2. Key Country Dynamics
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Reimbursement Scenario
      • 7.3.7.5. Competitive Scenario
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.3.8.2. Key Country Dynamics
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Reimbursement Scenario
      • 7.3.8.5. Competitive Scenario
    • 7.3.9. Norway
      • 7.3.9.1. Norway Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.3.9.2. Key Country Dynamics
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Reimbursement Scenario
      • 7.3.9.5. Competitive Scenario
  • 7.4. Asia Pacific
    • 7.4.1. Asia-Pacific Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Japan Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.4.2.2. Key Country Dynamics
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Reimbursement Scenario
      • 7.4.2.5. Competitive Scenario
    • 7.4.3. China
      • 7.4.3.1. China Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.4.3.2. Key Country Dynamics
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Reimbursement Scenario
      • 7.4.3.5. Competitive Scenario
    • 7.4.4. India
      • 7.4.4.1. India Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.4.4.2. Key Country Dynamics
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Reimbursement Scenario
      • 7.4.4.5. Competitive Scenario
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.4.5.2. Key Country Dynamics
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Reimbursement Scenario
      • 7.4.5.5. Competitive Scenario
    • 7.4.6. Thailand
      • 7.4.6.1. Thailand Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.4.6.2. Key Country Dynamics
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Reimbursement Scenario
      • 7.4.6.5. Competitive Scenario
    • 7.4.7. Australia
      • 7.4.7.1. Australia Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.4.7.2. Key Country Dynamics
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Reimbursement Scenario
      • 7.4.7.5. Competitive Scenario
  • 7.5. Latin America
    • 7.5.1. Latin America Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.5.2.2. Key Country Dynamics
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement Scenario
      • 7.5.2.5. Competitive Scenario
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.5.3.2. Key Country Dynamics
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement Scenario
      • 7.5.3.5. Competitive Scenario
  • 7.6. MEA
    • 7.6.1. MEA Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.6.2.2. Key Country Dynamics
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement Scenario
      • 7.6.2.5. Competitive Scenario
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Saudi Arabia Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.6.3.2. Key Country Dynamics
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement Scenario
      • 7.6.3.5. Competitive Scenario
    • 7.6.4. UAE
      • 7.6.4.1. UAE Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.6.4.2. Key Country Dynamics
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement Scenario
      • 7.6.4.5. Competitive Scenario
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
      • 7.6.5.2. Key Country Dynamics
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement Scenario
      • 7.6.5.5. Competitive Scenario

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
    • 8.2.1. New Product Launch
    • 8.2.2. Partnerships
    • 8.2.3. Acquisition
    • 8.2.4. Collaboration
    • 8.2.5. Funding
  • 8.3. Key Company Market Share Analysis, 2024
  • 8.4. Company Heat Map Analysis
  • 8.5. Company Profiles
    • 8.5.1. F. Hoffmann-La Roche Ltd
      • 8.5.1.1. Company Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Molbio Diagnostics Limited
      • 8.5.2.1. Company Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Becton, Dickinson and Company
      • 8.5.3.1. Company Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Danaher Corporation
      • 8.5.4.1. Company Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Abbott Laboratories
      • 8.5.5.1. Company Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Illumina, Inc.
      • 8.5.6.1. Company Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Siemens Healthineers
      • 8.5.7.1. Company Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. bioMerieux SA
      • 8.5.8.1. Company Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Bio-Rad Laboratories, Inc.
      • 8.5.9.1. Company Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Seegene Inc.
      • 8.5.10.1. Company Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global Nucleic Acid Amplification Testing Market, By Region, 2021 - 2033 (USD Million)
  • Table 4 Global Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 5 Global Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 6 Global Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 7 North America Nucleic Acid Amplification Testing Market, By Country, 2021 - 2033 (USD Million)
  • Table 8 North America Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 9 North America Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 10 North America Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 11 U.S. Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 12 U.S. Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 13 U.S. Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 14 Canada Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 15 Canada Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 16 Canada Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 17 Mexico Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 18 Mexico Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 19 Mexico Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 20 Europe Nucleic Acid Amplification Testing Market, By Country, 2021 - 2033 (USD Million)
  • Table 21 Europe Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 22 Europe Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 23 Europe Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 24 UK Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 25 UK Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 26 UK Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 27 Germany Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 28 Germany Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 29 Germany Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 30 France Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 31 France Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 32 France Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 33 Italy Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 34 Italy Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 35 Italy Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 36 Spain Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 37 Spain Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 38 Spain Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 39 Sweden Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 40 Sweden Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 41 Sweden Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 42 Norway Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 43 Norway Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 44 Norway Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 45 Denmark Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 46 Denmark Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 47 Denmark Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific Nucleic Acid Amplification Testing Market, By Country, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 51 Asia Pacific Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 52 Japan Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 53 Japan Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 54 Japan Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 55 China Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 56 China Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 57 China Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 58 India Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 59 India Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 60 India Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 61 Australia Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 62 Australia Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 63 Australia Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 64 Thailand Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 65 Thailand Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 66 Thailand Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 67 South Korea Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 68 South Korea Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 69 South Korea Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 70 Latin America Nucleic Acid Amplification Testing Market, By Country, 2021 - 2033 (USD Million)
  • Table 71 Latin America Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 72 Latin America Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 73 Latin America Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 74 Brazil Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 75 Brazil Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 76 Brazil Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 77 Argentina Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 78 Argentina Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 79 Argentina Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 80 MEA Nucleic Acid Amplification Testing Market, By Country, 2021 - 2033 (USD Million)
  • Table 81 MEA Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 82 MEA Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 83 MEA Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 84 South Africa Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 85 South Africa Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 86 South Africa Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 89 Saudi Arabia Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 90 UAE Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 91 UAE Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 92 UAE Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)
  • Table 93 Kuwait Nucleic Acid Amplification Testing Market, By Type, 2021 - 2033 (USD Million)
  • Table 94 Kuwait Nucleic Acid Amplification Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 95 Kuwait Nucleic Acid Amplification Testing Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Global Nucleic Acid Amplification Testing Market - Key market driver analysis
  • Fig. 7 Global Nucleic Acid Amplification Testing Market - Key market restraint analysis
  • Fig. 8 Penetration & growth prospect mapping
  • Fig. 9 Global Nucleic Acid Amplification Testing Market - Porter's analysis
  • Fig. 10 Global Nucleic Acid Amplification Testing Market - PESTEL analysis
  • Fig. 11 Global Nucleic Acid Amplification Testing Market: Type outlook key takeaways
  • Fig. 12 Global Nucleic Acid Amplification Testing Market: Type movement analysis
  • Fig. 13 Polymerase Chain Reaction (PCR) Tests Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 14 Isothermal Nucleic Acid Amplification Technology (INAAT) Tests Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 15 Ligase Chain Reaction (LCR) Tests Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 16 Global Nucleic Acid Amplification Testing Market Application Outlook Key Takeaways
  • Fig. 17 Global Nucleic Acid Amplification Testing Market: Application movement analysis
  • Fig. 18 Infectious Disease Testing Nucleic Acid Amplification Testing Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 19 COVID-19 Testing Nucleic Acid Amplification Testing Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 20 Mosquito-Borne Disease Testing Nucleic Acid Amplification Testing Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 21 Sexually Transmitted Infections Testing Nucleic Acid Amplification Testing Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 22 Hepatitis Testing Nucleic Acid Amplification Testing Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 23 Tuberculosis Testing Nucleic Acid Amplification Testing Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 24 Others Nucleic Acid Amplification Testing Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 25 Oncology Testing Nucleic Acid Amplification Testing Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 26 Genetic & Mitochondrial Disease Testing Nucleic Acid Amplification Testing Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 27 Others Testing Nucleic Acid Amplification Testing Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 28 Global Nucleic Acid Amplification Testing Market: End Use Outlook Key Takeaways
  • Fig. 29 Global Nucleic Acid Amplification Testing Market: End Use movement analysis
  • Fig. 30 Hospitals Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 31 Central And Reference Laboratories Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 32 Others Market Estimates, 2021 - 2033 (USD Million)
  • Fig. 33 Regional marketplace: Key takeaways
  • Fig. 34 Global Nucleic Acid Amplification Testing Market: Regional movement analysis
  • Fig. 35 North America Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 36 US Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 37 Canada Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 38 Mexico Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 39 Europe Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 40 UK Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 41 Germany Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 42 France Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 43 Spain Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 44 Italy Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 45 Denmark Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 46 Sweden Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 47 Norway Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 48 Asia Pacific Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 49 Japan Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 50 China Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 51 India Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 52 South Korea Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 53 Australia Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 54 Thailand Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 55 Latin America Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 56 Brazil Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 57 Argentina Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 58 MEA Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 59 South Africa Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 60 Saudi Arabia Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 61 UAE Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 62 Kuwait Nucleic Acid Amplification Testing Market, 2021 - 2033 (USD Million)
  • Fig. 63 Strategy framework